Meet our Myopia Trailblazers, representing CooperVision at IMC 2024. These dedicated researchers and program leaders have been pivotal in developing and advancing innovative solutions that are transforming children’s lives globally. Committed to making myopia management the standard of care, they share their journeys and reflect on the impact of their work. Together, they are shaping a brighter future for children's vision.
Paul Chamberlain - Senior Director, Research Programs, R&D
United States
“I lead a team of experienced clinical researchers driving research programs covering presbyopia, astigmatism, comfort and myopia. It's been a career highlight to work on the clinical trial of MiSight® 1 day. I've particularly enjoyed reviewing the data and analyzing it from the perspective of both a scientist and an optometrist to make sure that the work we do is truly relatable to those ECPs who are looking after the eyes of the myopic children they see every day. Through this research I've also been involved in supporting the regulatory processes in many countries which has ultimately increased the availability of myopia control to a wider community of children all over the world.”
Kathryn Richdale - Director, Post-Market Studies
United States
“I oversee post-approval, post-market clinical follow-up, and claims studies supporting our contact lens products worldwide. My work has expanded from direct patient care to teaching students and eye care providers, and I've published over 50 peer-reviewed articles in the fields of myopia and contact lenses.”
Pete Coldrey - Senior Research Program Manager
United States
“The greatest impact of my work has been facilitating clinical trials for next-generation myopia control designs and supporting world-leading scientists in R&D, driving innovation and advancing the field.”
Baskar Arumugam - Senior Lead Clinical Scientist
United States
“I conceive new ideas to improve myopia control efficacy and lead the myopia research program to design and collect data to support the development of new and improved products for myopia management.”
Arthur Bradley - Research Fellow
United States
“As a member of the R&D team, my expertise in optics and vison science allows me to support the development and evaluation of new contact lens technologies, including supporting the analysis and communication of findings from CooperVision’s pivotal seven year MiSight® 1 day study.”
Kelly Voltz - Lead Clinical Scientist
United States
“I hope to see an increase in public awareness and witness the shift from myopia management as the standard of care for practitioners to myopia management as the standard of care for patients and families.”
Elizabeth Lumb - Director, Global Professional Affairs, Myopia
United Kingdom
“I’m responsible for translating the science that underpins the myopia research to wide audiences of eye care professionals to drive change in prescribing behavior.”
Katie Harrop - Senior Manager, Global Professional Education
United Kingdom
“The greatest impact of my work in the field of myopia has been training hundreds of ECPs in ortho-k theory and practice over the past 20 years. This training has enabled them to offer overnight ortho-k to young myopic children, empowering these ECPs to make a real difference in children’s lives now and in the future.”
Amy Chow - Senior Brand Manager, Global Myopia Management
Canada
“I am proud to have worked with like-minded individuals to have driven a nationwide shift in Canada towards proactive myopia care.”
Stuart Cockerill - Head of Life Cycle Management for Myopia Management and Specialty Lenses
United Kingdom
“I lead the strategy for new product development in myopia control and cornea care, improving the lives of wearers every day. Leading the original MiSight® 1 day study has empowered us to raise awareness about myopia control, highlighting the risks of progressive myopia. This provides ECPs with compelling reasons to take action for every child they see, ensuring the best possible vision for their entire life.”
Chi Shing Fan - Director Professional and Clinical Affairs, Specialty EyeCare China
Hong Kong
“I lead the professional and clinical affairs teams in the largest myopic population market—China. In the next decade, I hope all healthcare professionals practice myopia management as their standard of care, and that every family around the world has access to—and is able to afford—effective myopia control options. Even more so, I hope to see breakthrough products for prevention instead of control.”
Tacy Song - Head of Professional Affairs, Myopia, APAC
Singapore
“The greatest impact of my work has been in uniting top experts in myopia control from optometry and ophthalmology worldwide to collaborate and share insights on evidence-based management practices, such as MiSight® 1 day and ortho-K, to align standards and approaches across disciplines.”
Johnathon Chua - Product Manager, Myopia, APAC
Singapore
“I’m responsible for promoting the importance of myopia management and the urgency to act with evidence-based treatments.”
Joanna Leong - Senior Business Manager, APAC
Singapore
“I would like to see clear vision and effective myopia control options within reach for all children with myopia worldwide, enabling them to pursue their ambitions.”
Loretta Li - Myopia Management Specialist
Australia
“By educating and shifting the mindset of our peers, my work empowers them to take proactive measures in myopia management, ultimately making a meaningful difference in children's lives.”
Felicia Timmerman - Senior Manager, Myopia Management
United States
“I have helped position CooperVision as a leader in the field of myopia management through strategic support and partnerships with academic programs, optometry and eye care organizations, and pediatric healthcare associations in the United States.”
Priscilla Chang - Senior Manager, Myopia Management
United States
“My greatest impact in the field is reflected in every child whose life has been positively changed by our products and every doctor who has adopted myopia management as the standard of care.”
Marcella McParland, Vice President Clinical, Medical and Professional Affairs SightGlassVision, and Senior Director Professional Affairs EMEA CooperVision
United Kingdom
“I lead and drive the development of science and clinical evidence for new myopia control Diffusion Optics Technology™ (DOT) spectacle lenses and oversee their global launch to eye care professionals. While it's still early, thousands of children in China are already benefiting from DOT lenses. Our team has provided the science and clinical evidence needed to encourage ECPs to adopt and prescribe this innovative technology.”
Marie Chanu - Senior Manager Professional Affairs Myopia Management, EMEA
Spain
“I’d love to see every ECP in EMEA recommending myopia management solutions to all children who need them.”